-
Tytuł:
-
E-cigarette use and respiratory symptoms in residents of the United States: A BRFSS report.
-
Autorzy:
-
Varella MH; Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
Andrade OA; American University of Antigua College of Medicine, United States of America.
Shaffer SM; American University of Antigua College of Medicine, United States of America.
Castro G; Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
Rodriguez P; Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
Barengo NC; Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.; Department of Health Policy and Management, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, United States of America.; Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Acuna JM; Department of Epidemiology and Aw 8474000331 R-DISC, Khalifa University, Abu Dhabi, United Arab Emirates.; CRUSADA, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, United States of America.
-
Źródło:
-
PloS one [PLoS One] 2022 Dec 01; Vol. 17 (12), pp. e0269760. Date of Electronic Publication: 2022 Dec 01 (Print Publication: 2022).
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: San Francisco, CA : Public Library of Science
-
MeSH Terms:
-
Vaping*/adverse effects
Vaping*/epidemiology
Electronic Nicotine Delivery Systems*
Asthma*
Adult ; United States/epidemiology ; Humans ; Behavioral Risk Factor Surveillance System ; Cough
-
References:
-
Biomed Res Int. 2019 Dec 19;2019:1386710. (PMID: 31950030)
MMWR Surveill Summ. 2022 Mar 11;71(5):1-29. (PMID: 35271557)
Ann Intern Med. 2018 Oct 2;169(7):429-438. (PMID: 30167658)
BMC Public Health. 2014 Nov 08;14:1159. (PMID: 25380748)
Eur Respir J. 2021 Jan 21;57(1):. (PMID: 33154031)
Am J Respir Crit Care Med. 2018 Feb 15;197(4):492-501. (PMID: 29053025)
Rev Invest Clin. 2019;71(1):17-27. (PMID: 30810544)
BMC Pulm Med. 2019 Oct 16;19(1):180. (PMID: 31619218)
JAMA Netw Open. 2020 Oct 1;3(10):e2020671. (PMID: 33048131)
J Public Health Policy. 2011 Feb;32(1):16-31. (PMID: 21150942)
JAMA Netw Open. 2020 Jan 3;3(1):e1920255. (PMID: 32003818)
Environ Health Perspect. 2016 Jun;124(6):733-9. (PMID: 26642857)
Am J Prev Med. 2020 Feb;58(2):182-190. (PMID: 31859175)
JAMA Pediatr. 2016 Jan;170(1):89-91. (PMID: 26551991)
JAMA Netw Open. 2020 Nov 2;3(11):e2020816. (PMID: 33180127)
Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216. (PMID: 33913154)
Ann Intern Med. 2019 Jan 1;170(1):76-79. (PMID: 30304466)
Public Health Rep. 2020 Nov/Dec;135(6):785-795. (PMID: 32972319)
Am J Respir Crit Care Med. 2017 Apr 15;195(8):1043-1049. (PMID: 27806211)
-
Entry Date(s):
-
Date Created: 20221201 Date Completed: 20221205 Latest Revision: 20230109
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC9714717
-
DOI:
-
10.1371/journal.pone.0269760
-
PMID:
-
36454742
-
Purpose: E-cigarettes are the most common type of electronic nicotine delivery system in the United States. E-cigarettes contain numerous toxic compounds that has been shown to induce severe structural damage to the airways. The objective of this study is to assess if there is an association between e-cigarette use and respiratory symptoms in adults in the US as reported in the BRFSS.
Methods: We analyzed data from 18,079 adults, 18-44 years, who participated at the Behavioral Risk Factor Surveillance System (BRFSS) in the year 2017. E-cigarette smoking status was categorized as current everyday user, current some days user, former smoker, and never smoker. The frequency of any respiratory symptoms (cough, phlegm, or shortness of breath) was compared. Unadjusted and adjusted logistic regression analysis were used to calculate odds ratios (OR) and 95% confidence intervals (CI).
Results: The BRFSS reported prevalence of smoking e-cigarettes was 6%. About 28% of the participants reported any of the respiratory symptoms assessed. The frequency of reported respiratory symptoms was highest among current some days e-cigarette users (45%). After adjusting for selected participant's demographic, socio-economic, and behavioral characteristics, and asthma and COPD status, the odds of reporting respiratory symptoms increased by 49% among those who use e-cigarettes some days (OR 1.49; 95% CI: 1.06-2.11), and by 29% among those who were former users (OR 1.29; 95% CI: 1.07-1.55) compared with those who never used e-cigarettes. No statistically significant association was found for those who used e-cigarettes every day (OR 1.41; 95% CI 0.96-2.08).
Conclusion: E-cigarettes cannot be considered as a safe alternative to aid quitting use of combustible traditional cigarettes. Cohort studies may shed more evidence on the association between e-cigarette use and respiratory diseases.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2022 Varella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
